The estimated Net Worth of John Edward Lynch is at least $50.3 Tysiąc dollars as of 31 May 2022. John Lynch owns over 37,500 units of IGC Pharma Inc stock worth over $50,333 and over the last 2 years John sold IGC stock worth over $0.
John has made over 1 trades of the IGC Pharma Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently John exercised 37,500 units of IGC stock worth $14,044 on 31 May 2022.
The largest trade John's ever made was exercising 37,500 units of IGC Pharma Inc stock on 31 May 2022 worth over $14,044. On average, John trades about 37,500 units every 0 days since 2022. As of 31 May 2022 John still owns at least 134,401 units of IGC Pharma Inc stock.
You can see the complete history of John Lynch stock trades at the bottom of the page.
Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira oraz Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
IGC Pharma Inc executives and other stock owners filed with the SEC include: